Mr. Hanson is the CEO of Solventum, an $8.2 billion independent healthcare company dedicated to advancing medical innovation across surgical, dental, health information and filtration solutions. Leading 22,000 professionals, he drives transformative advancements that enhance patient outcomes, empower healthcare providers and optimize system efficiency. With over 33 years of experience, Mr. Hanson has successfully led and expanded global medical device businesses at Zimmer Biomet, Medtronic and Covidien, fostering innovation and commercial success. His leadership at Solventum has positioned the company to pioneer game-changing solutions at the intersection of health, material and data science. Passionate about transformation and value creation, he is committed to improving patient experiences while delivering long-term returns for shareholders. Mr. Hanson also serves on the board of directors of Walgreens Boots Alliance.
